LKB1 loss is a novel genomic predictor of de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma Meeting Abstract
| Authors: | Skoulidis, F.; Hellman, M. D.; Awad, M.; Gainor, J. F.; Rizvi, H.; Carter, B.; Denning, W. L.; Villalobos, P.; Parra, E. R.; Elamin, Y. Y.; Zhang, J.; Leonardi, G. C.; Halpenny, D. F.; Papadimitrakopoulou, V.; Wistuba, I. I.; Wolchok, J. D.; Shaw, A. T.; Jänne, P. A.; Rudin, C. M.; Heymach, J. V. |
| Abstract Title: | LKB1 loss is a novel genomic predictor of de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx380.014 |
| Language: | English |
| ACCESSION: | WOS:000411324003160 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx380.014 |
| Notes: | Meeting Abstract: 1311P -- Appears on page 467 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work